세계의 위암 진단 절차 시장 보고서(2025년)

The diagnostic procedure for gastric cancer involves the identification and treatment of cancerous cells in the stomach. This procedure is crucial for diagnosing stomach cancer.

Key procedures in the diagnostic process for gastric cancer include endoscopic procedures, biopsies, tissue tests, laboratory tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The endoscopic procedure involves the examination of internal organs, such as the gastrointestinal tract, by inserting a long, thin tube directly into the body. This endoscopy procedure is utilized in gastric cancer diagnosis, addressing both symptomatic and asymptomatic cases, and encompasses instruments, reagents and consumables, and services. Various body fluids, including blood, urine, saliva, stomach juice, and tissue, are required for the procedure. These fluids aid in the detection and treatment of both early and advanced gastric cancer.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The gastric cancer diagnostic procedure market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic procedure market statistics, including the gastric cancer diagnostic procedure industry's global market size, regional shares, competitors with a gastric cancer diagnostic procedure market share, detailed gastric cancer diagnostic procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic procedure industry. This gastric cancer diagnostic procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to innovations in biopsy techniques, increased research funding, evolution of biomarker discovery, improved pathological analysis, shifts in screening guidelines.

The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rise in point-of-care testing, introduction of novel biomarkers, shift towards personalized medicine, adoption of next-generation sequencing, enhanced endoscopic imaging modalities. Major trends in the forecast period include integration of nanotechnology, adoption of big data analytics, application of microbiota analysis, increased patient-centric approaches, role of telehealth in diagnostics.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge by increasing costs for endoscopic ultrasound (EUS) scopes and biopsy forceps sourced from Japan and the Netherlands, potentially compromising early detection and raising gastrointestinal(GI) endoscopy unit expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of gastrointestinal diseases is a driving force behind the anticipated growth in the gastric cancer diagnostic procedure market. Gastrointestinal disorders encompass a range of illnesses affecting various sections of the digestive system and supporting organs, including the liver and pancreas. The gastric cancer diagnostic procedure is essential for addressing stomach cancer through methods such as endoscopy and biopsy. Therefore, the expanding incidence of gastrointestinal diseases is contributing to the market's growth. For instance, a study conducted by GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, involved 73,076 people from 33 nations, revealing that 40% of the subjects suffered from a functional gastrointestinal illness in August 2022. Hence, the increasing prevalence of gastrointestinal diseases is a significant factor propelling the growth of the gastric cancer diagnostic procedure market.

The rising prevalence of smoking is expected to drive the growth of the gastric cancer diagnostic procedure market in the future. Smoking involves the inhalation and exhalation of smoke produced by burning tobacco or other substances. Gastric cancer diagnostic procedures play a crucial role for individuals with a history of smoking or those at risk of smoking-related cancers by enabling early detection, identifying precancerous lesions, developing personalized treatment plans, facilitating communication and coordination, and providing a comprehensive assessment of the gastric mucosa and surrounding tissues. According to a report by The World Health Organization, a Switzerland-based intergovernmental organization, in July 2023, more than 8 million people are killed by tobacco each year, including 1.3 million non-smokers who inhale second-hand smoke. Therefore, the rising prevalence of smoking is a key driver of the growth of the gastric cancer diagnostic procedure market.

Technological advancements represent a prominent trend gaining momentum in the gastric cancer diagnostic market. Leading companies in the gastric cancer diagnostic market are actively incorporating new technologies to maintain their competitive positions. For example, in June 2022, Ibex Medical Analytics, an Israel-based provider of AI-powered diagnostics for health organizations, introduced Galen Gastric, the world's first AI-powered solution designed for gastric cancer detection. Galen Gastric serves as an integrated diagnostic tool assisting pathologists in identifying stomach cancer, H. pylori, and other critical clinical findings, contributing to faster turnaround times and improved diagnostic workflows.

Prominent companies in the gastric cancer diagnostic procedure market are strategically focusing on innovative products such as tissue staining platforms to drive revenue growth. The tissue staining platform aims to deliver rapid and precise test results, enabling medical professionals to make timely decisions regarding patient care. In June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced the benchmark ultra plus system. This system, building on the proven technology of the benchmark ultra system, provides a fully automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining. It enhances the laboratory experience with features such as a retractable work surface, improved sliding drawers, indicator lights, and remote monitoring via a connected device, addressing user feedback. The system emphasizes efficient workflow, testing efficiency, and eco-friendly attributes.

In March 2023, Pfizer, a pharmaceutical corporation based in the United States, acquired Seagen Inc. for $43 billion. This acquisition strengthens Pfizer's position as a leading player in the oncology market by incorporating Seagen's groundbreaking antibody-drug conjugate (ADC) technology and expanding its portfolio of innovative cancer therapies. Seagen Inc. is a US-based biotechnology company focused on the discovery, development, and commercialization of transformative cancer medicines.

Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric cancer diagnostic procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric cancer diagnostics procedure market includes revenues earned by entities that provide diagnostic procedures such as surgery, chemotherapy, and radiation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Procedure Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric cancer diagnostic procedure market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic procedure ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer diagnostic procedure market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue Tests; Lab Tests; In-Vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types
• 2) By Symptom Type: Symptomatic; Asymptomatic
• 3) By Offering Type: Instruments; Reagents And Consumables; Services
• 4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid
• 5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer
• Subsegments:
• 1) By Endoscopic Procedure: Upper Endoscopy (EGD); Endoscopic Ultrasound (EUS)
• 2) By Biopsy: Endoscopic Biopsy; Fine Needle Aspiration (FNA) Biopsy
• 3) By Tissue Tests: Histopathology; Immunohistochemistry
• 4) By Lab Tests: Blood Tests; Tumor Markers
• 5) By In-Vitro Diagnostic Tests: Genetic Testing; Molecular Profiling
• 6) By Imaging Tests: Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scan
• 7) By Molecular Diagnostics: PCR Testing; Next-Generation Sequencing (NGS)
• 8) By Multiplexing Molecular Diagnostics: Multiplex PCR; Microarray Analysis
• 9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
• 10) By Other Procedure Types: Breath Tests; Liquid Biopsies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Co; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; AstraZeneca plc; Abbott Laboratories Inc.; Sanofi SA; Eli Lilly and Company; Otsuka Pharmaceutical Co Ltd.; AdventHealth; Atrium Health; Astellas Pharma Inc; Bausch Health Companies Inc.; Agilent Technologies Inc.; Ipsen Pharma; Hartford HealthCare; Myriad Genetics Inc.; NovoCure Limited; Foundation Medicine Inc.; Biocept Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastric Cancer Diagnostic Procedure Market Characteristics

3. Gastric Cancer Diagnostic Procedure Market Trends And Strategies

4. Gastric Cancer Diagnostic Procedure Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gastric Cancer Diagnostic Procedure Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastric Cancer Diagnostic Procedure PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastric Cancer Diagnostic Procedure Market Growth Rate Analysis
• 5.4. Global Gastric Cancer Diagnostic Procedure Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastric Cancer Diagnostic Procedure Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastric Cancer Diagnostic Procedure Total Addressable Market (TAM)

6. Gastric Cancer Diagnostic Procedure Market Segmentation

• 6.1. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopic Procedure
• Biopsy
• Tissue Tests
• Lab Tests
• In-Vitro Diagnostic Tests
• Imaging Tests
• Molecular Diagnostics
• Multiplexing Molecular Diagnostics
• Immunoassays
• Other Procedure Types
• 6.2. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Symptomatic
• Asymptomatic
• 6.3. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents and Consumables
• Services
• 6.4. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Urine
• Saliva
• Stomach Juice
• Tissue
• Other Body Fluid
• 6.5. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Gastric Cancer
• Advanced Gastric Cancer
• 6.6. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Endoscopic Procedure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upper Endoscopy (EGD)
• Endoscopic Ultrasound (EUS)
• 6.7. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopic Biopsy
• Fine Needle Aspiration (FNA) Biopsy
• 6.8. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Tissue Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Histopathology
• Immunohistochemistry
• 6.9. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Lab Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Tumor Markers
• 6.10. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing
• Molecular Profiling
• 6.11. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET) Scan
• 6.12. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Testing
• Next-Generation Sequencing (NGS)
• 6.13. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Multiplexing Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multiplex PCR
• Microarray Analysis
• 6.14. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Immunoassays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• 6.15. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Other Procedure Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breath Tests
• Liquid Biopsies

7. Gastric Cancer Diagnostic Procedure Market Regional And Country Analysis

• 7.1. Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastric Cancer Diagnostic Procedure Market

• 8.1. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastric Cancer Diagnostic Procedure Market

• 9.1. China Gastric Cancer Diagnostic Procedure Market Overview
• 9.2. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastric Cancer Diagnostic Procedure Market

• 10.1. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastric Cancer Diagnostic Procedure Market

• 11.1. Japan Gastric Cancer Diagnostic Procedure Market Overview
• 11.2. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastric Cancer Diagnostic Procedure Market

• 12.1. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastric Cancer Diagnostic Procedure Market

• 13.1. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastric Cancer Diagnostic Procedure Market

• 14.1. South Korea Gastric Cancer Diagnostic Procedure Market Overview
• 14.2. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastric Cancer Diagnostic Procedure Market

• 15.1. Western Europe Gastric Cancer Diagnostic Procedure Market Overview
• 15.2. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastric Cancer Diagnostic Procedure Market

• 16.1. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastric Cancer Diagnostic Procedure Market

• 17.1. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastric Cancer Diagnostic Procedure Market

• 18.1. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastric Cancer Diagnostic Procedure Market

• 19.1. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastric Cancer Diagnostic Procedure Market

• 20.1. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastric Cancer Diagnostic Procedure Market

• 21.1. Eastern Europe Gastric Cancer Diagnostic Procedure Market Overview
• 21.2. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastric Cancer Diagnostic Procedure Market

• 22.1. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastric Cancer Diagnostic Procedure Market

• 23.1. North America Gastric Cancer Diagnostic Procedure Market Overview
• 23.2. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastric Cancer Diagnostic Procedure Market

• 24.1. USA Gastric Cancer Diagnostic Procedure Market Overview
• 24.2. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastric Cancer Diagnostic Procedure Market

• 25.1. Canada Gastric Cancer Diagnostic Procedure Market Overview
• 25.2. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastric Cancer Diagnostic Procedure Market

• 26.1. South America Gastric Cancer Diagnostic Procedure Market Overview
• 26.2. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastric Cancer Diagnostic Procedure Market

• 27.1. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastric Cancer Diagnostic Procedure Market

• 28.1. Middle East Gastric Cancer Diagnostic Procedure Market Overview
• 28.2. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastric Cancer Diagnostic Procedure Market

• 29.1. Africa Gastric Cancer Diagnostic Procedure Market Overview
• 29.2. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastric Cancer Diagnostic Procedure Market Competitive Landscape And Company Profiles

• 30.1. Gastric Cancer Diagnostic Procedure Market Competitive Landscape
• 30.2. Gastric Cancer Diagnostic Procedure Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Gastric Cancer Diagnostic Procedure Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories Inc.
• 31.6. Sanofi SA
• 31.7. Eli Lilly and Company
• 31.8. Otsuka Pharmaceutical Co Ltd.
• 31.9. AdventHealth
• 31.10. Atrium Health
• 31.11. Astellas Pharma Inc
• 31.12. Bausch Health Companies Inc.
• 31.13. Agilent Technologies Inc.
• 31.14. Ipsen Pharma
• 31.15. Hartford HealthCare

32. Global Gastric Cancer Diagnostic Procedure Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Procedure Market

34. Recent Developments In The Gastric Cancer Diagnostic Procedure Market

35. Gastric Cancer Diagnostic Procedure Market High Potential Countries, Segments and Strategies

• 35.1 Gastric Cancer Diagnostic Procedure Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastric Cancer Diagnostic Procedure Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastric Cancer Diagnostic Procedure Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer